Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
HR-positive, HER2-negative advanced, metastatic, or high-risk early Breast Cancer.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Ovarian Cancer, Kaposi Sarcoma, and Lymphomas.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
NTRK gene fusion-positive solid tumors across all tissue origins.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).